Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital

Background and objectives: Thiopurines are an effective treatment for the maintenance of remission in inflammatory bowel disease (IBD). They can present adverse effects (AEs), with myelotoxicity being the most relevant. This study aims to determine the incidence of AEs related to the starting of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau, Gerard, Brunet-Mas, Eduard, Llovet, Laura Patricia, Pedregal, Patricia, Villoria, Albert, Melcarne, Luigi, Puy, Anna, Garcia-Sague, Belen, Frisancho, Luis Enrique, Ramírez-Lázaro, María José, Lario, Sergio, Calvet, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607915/
https://www.ncbi.nlm.nih.gov/pubmed/37892708
http://dx.doi.org/10.3390/jcm12206571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607915/
https://www.ncbi.nlm.nih.gov/pubmed/37892708
http://dx.doi.org/10.3390/jcm12206571

Ejemplares similares